Published in BMC Musculoskelet Disord on October 10, 2010
Bone Morphogenetic Protein (BMP) signaling in development and human diseases. Genes Dis (2014) 1.27
Progress in intra-articular therapy. Nat Rev Rheumatol (2013) 1.24
Functional articular cartilage repair: here, near, or is the best approach not yet clear? Nat Rev Rheumatol (2013) 1.09
Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol (2013) 1.07
State-of-the-Art management of knee osteoarthritis. World J Clin Cases (2015) 1.06
Role of bone architecture and anatomy in osteoarthritis. Bone (2012) 1.03
New findings in osteoarthritis pathogenesis: therapeutic implications. Ther Adv Chronic Dis (2013) 1.00
Targets, models and challenges in osteoarthritis research. Dis Model Mech (2015) 0.99
Emerging targets in osteoarthritis therapy. Curr Opin Pharmacol (2015) 0.97
Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res (2016) 0.92
Regulation of chondrocyte gene expression by osteogenic protein-1. Arthritis Res Ther (2011) 0.90
Signaling pathways in cartilage repair. Int J Mol Sci (2014) 0.86
Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain. J Bone Miner Res (2016) 0.83
Stem cells and other innovative intra-articular therapies for osteoarthritis: what does the future hold? BMC Med (2012) 0.82
Biochemical characterization of early osteoarthritis in the ankle. ScientificWorldJournal (2014) 0.81
Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches. Arthritis (2012) 0.81
Immunohistological localization of BMP-2, BMP-7, and their receptors in knee joints with focal cartilage lesions. ScientificWorldJournal (2012) 0.80
Efficacy Evaluation of a New Hyaluronan Derivative HYADD(®) 4-G to Maintain Cartilage Integrity in a Rabbit Model of Osteoarthritis. Cartilage (2013) 0.80
Are applied growth factors able to mimic the positive effects of mesenchymal stem cells on the regeneration of meniscus in the avascular zone? Biomed Res Int (2014) 0.79
Bone morphogenetic proteins and their antagonists: current and emerging clinical uses. Br J Pharmacol (2014) 0.79
Enhanced healing of rat calvarial defects with MSCs loaded on BMP-2 releasing chitosan/alginate/hydroxyapatite scaffolds. PLoS One (2014) 0.78
Key Pathways to Prevent Posttraumatic Arthritis for Future Molecule-Based Therapy. Cartilage (2013) 0.76
Osteoarthritis, a disease bridging development and regeneration. Bonekey Rep (2012) 0.76
Therapeutic effects of OP-1 on metal wear particle induced osteoblasts injury in vitro. Int J Clin Exp Med (2015) 0.75
BMP-7 Induces Adult Human Pancreatic Exocrine-to-Endocrine Conversion. Diabetes (2015) 0.75
The state of cartilage regeneration: current and future technologies. Curr Rev Musculoskelet Med (2015) 0.75
Cartilage-targeting drug delivery: can electrostatic interactions help? Nat Rev Rheumatol (2017) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol (1988) 35.68
Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure. J Orthop Sports Phys Ther (1998) 10.08
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Prevalence of disabilities and associated health conditions among adults--United States, 1999. MMWR Morb Mortal Wkly Rep (2001) 5.14
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage (2004) 4.01
Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev (2009) 2.57
Management of common musculoskeletal problems: a survey of Ontario primary care physicians. CMAJ (1998) 2.41
The TGF-beta family and its composite receptors. Trends Cell Biol (1994) 2.36
Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. Proc Natl Acad Sci U S A (1996) 1.71
Arthritis prevalence and activity limitations in older adults. Arthritis Rheum (2001) 1.65
Overview of bone morphogenetic proteins. Spine (Phila Pa 1976) (2002) 1.52
Regeneration of articular cartilage chondral defects by osteogenic protein-1 (bone morphogenetic protein-7) in sheep. Growth Factors (2001) 1.39
The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Joint Surg Am (1997) 1.25
Osteogenic protein-1: biology and applications. Clin Orthop Relat Res (1996) 1.16
Repair of articular cartilage defects with osteogenic protein-1 (BMP-7) in dogs. J Bone Joint Surg Am (2003) 1.14
Alterations in endogenous osteogenic protein-1 with degeneration of human articular cartilage. J Orthop Res (2003) 1.02
Osteogenic Protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis. Osteoarthritis Cartilage (2004) 1.01
Prevalence and impact of chronic joint symptoms--seven states, 1996. MMWR Morb Mortal Wkly Rep (1998) 0.88
Effect of polymerized-type I collagen in knee osteoarthritis. II. In vivo study. Eur J Clin Invest (2009) 0.84
[Targeted anti-cytokine therapies for osteoarthritis]. Bull Acad Natl Med (2006) 0.83
Effect of polymerized-type I collagen in knee osteoarthritis. I. In vitro study. Eur J Clin Invest (2009) 0.81
Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med (2007) 4.12
B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum (2009) 2.26
The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis Rheum (2008) 2.13
The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol (2006) 1.82
American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice. Arthritis Care Res (Hoboken) (2012) 1.63
Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis. J Rheumatol (2013) 1.45
Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans. Arthritis Rheum (2010) 1.34
Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis. Arthritis Rheum (2006) 1.28
Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis. J Med Internet Res (2004) 1.21
Associations of cigarette smoking with rheumatoid arthritis in African Americans. Arthritis Rheum (2010) 1.09
The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study. Spine (Phila Pa 1976) (2008) 1.09
Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clin Rheumatol (2007) 1.03
Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data. J Natl Med Assoc (2005) 1.02
Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen. Arthritis Rheum (2004) 0.98
Radiographic severity of rheumatoid arthritis in African Americans: results from a multicenter observational study. Arthritis Care Res (Hoboken) (2010) 0.98
A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis. Arthritis Rheum (2010) 0.87
Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African Americans. Arthritis Rheum (2012) 0.87
Levamisole toxicity mimicking autoimmune disease. J Am Acad Dermatol (2013) 0.86
Competency-based goals, objectives, and linked evaluations for rheumatology training programs: a standardized template of learning activities from the Carolinas Fellows Collaborative. Arthritis Care Res (Hoboken) (2013) 0.85
Ultrasound as an Outcome Measure in Gout. A Validation Process by the OMERACT Ultrasound Working Group. J Rheumatol (2015) 0.84
Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis. Drugs Aging (2015) 0.84
Genetic variants of STAT4 associated with rheumatoid arthritis in persons of Asian and European ancestry do not replicate in African Americans. Ann Rheum Dis (2010) 0.84
Retraction: an African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans. PLoS Genet (2009) 0.83
Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis. Arthritis Res Ther (2010) 0.83
Socioeconomic disparities in the health of african americans with rheumatoid arthritis from the southeastern United States. Arthritis Care Res (Hoboken) (2014) 0.79
Retracted An African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans. PLoS Genet (2009) 0.78
Patient-rheumatologist communication concerning prescription medications: getting to the gist. Arthritis Care Res (Hoboken) (2014) 0.78
Medication risk communication during rheumatology office visits. Arthritis Care Res (Hoboken) (2015) 0.77
Complementary and alternative medicine use in African Americans with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2014) 0.77
Pathologic fracture of the hip due to severe gouty arthritis. J Rheumatol (2006) 0.75